Search results for: AZOLE ANTIFUNGALS

• The impact of various azole antifungals on the liquid crystalline ordering in itraconazole

  Publication

  • D. Heczko
  • E. Kamińska
  • K. Jurkiewicz
  • M. Tarnacka
  • K. Merkel
  • K. Kamiński
  • M. Paluch

  - Journal of Molecular Liquids - Year 2020

  Full text to download in external service

• Pharmaceuticals and other contaminants of emerging concern in Admiralty Bay as a result of untreated wastewater discharge: Status and possible environmental consequences

  Publication

  • M. Szopińska
  • J. Potapowicz
  • K. Jankowska
  • A. Łuczkiewicz
  • O. Svahn
  • E. Björklund
  • C. Nannou
  • D. Lambropoulou
  • Ż. Polkowska

  - SCIENCE OF THE TOTAL ENVIRONMENT - Year 2022

  Considering how the impact of human activity in Antarctica is growing, the aim of this study was to conduct the first assessment of pharmaceuticals and personal care products (PPCPs), other emerging contaminants (ECs), and antibiotic resistance genes present in the western shore of the Admiralty Bay region of King George Island. In total, more than 170 substances were evaluated to assess the potential environmental risks they pose...

  Full text available to download

• Mechanisms of azole resistance among clinical isolates of Candida glabrata in Poland

  Publication

  • P. Szweda
  • K. M. Gucwa
  • E. Romanowska
  • K. Dzierżanowska-Fangrat
  • Ł. Naumiuk
  • A. Brillowska-Dąbrowska
  • I. Wojciechowska-Koszko
  • S. Milewski

  - JOURNAL OF MEDICAL MICROBIOLOGY - Year 2015

  Candida glabrata is currently ranked as the second most frequently isolated aetiological agent of human fungal infections, next only to Candida albicans. In comparison with C. albicans, C. glabrata shows lower susceptibility to azoles, the most common agents used in treatment of fungal infections. Interestingly, the mechanisms of resistance to azole agents in C. albicans have been much better investigated than those in C. glabrata....

  Full text available to download